Microvascular decompression (MVD) successfully treats trigeminal neuralgia (TGN), hemifacial spasm (HFS), glossopharyngeal neuralgia (GPN), and geniculate neuralgia (GN) by relieving root exit zone) vascular compression on cranial nerve (CN) V, CN VII, CN IX, and the nervous intermedius.
Introduction leading to postoperative hearing loss (HL)
4 at a rate of 1 to 23.8%. 2, [5] [6] [7] Monitoring intraoperative brainstem auditory evoked potential (BAEP) reduces postoperative CN VIII morbidity and remains the most effective method to prevent HL during MVD. 8 The American Clinical Neurophysiology Society (ACNS) and American Society of Neurophysiological Monitoring recommend alerting the surgeon when significant changes (SCs) in BAEPs occur to prevent HL. SCs happen when wave V latency increases ! 1.0 ms and/or amplitude decreases ! 50%. 9, 10 Currently, no pharmacological therapeutic options are available to treat the patients based on BAEP changes. Our primary objective is to perform a comprehensive systematic review of published studies to evaluate the diagnostic accuracy of BAEP during MVD to predict HL. We calculated the sensitivity, specificity, diagnostic odds ratio (DOR), and summary receiver operating curves (SROC) to quantify diagnostic accuracy. The secondary objective was to assess heterogeneity amongst studies qualitatively using Quality assessment of diagnostic accuracy studies-2 (QUADAS-2) and quantitatively using I
2
. This information will establish BAEPs are a real-time biomarker of HL during MVD.
Methods Literature Search and Strategy
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for a meta-analysis were followed. The PubMed/MEDLINE and World Science databases were searched systematically for articles using BAEPs to detect HL after MVD. Eligible studies were published through February 14, 2014 . The following keywords and Boolean operators were used: "auditory evoked response, auditory evoked potentials, brainstem auditory evoked potentials, brainstem auditory evoked response, intraoperative monitoring, or intraoperative neurophysiological monitoring" and "microvascular decompression, or MVD" and "hemifacial spasm, HFS, trigeminal neuralgia, TGN, tic douloureux, geniculate neuralgia, GN, nervus intermedius neuralgia, or glossopharyngeal neuralgia." Found article's reference lists were cross-checked for additional articles. We specified search, inclusion, and exclusion criteria a priori. Two investigators independently extracted data to minimize and prevent sources of bias common in observational studies.
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Study Selection
Included studies were randomized controlled trials, prospective or retrospective cohort reviews using BAEPs. All studies report hearing outcomes. The most detailed study data, or most recently published article, were chosen if studies presented duplicate data so that all cases were distinct. Excluded from this study are reviews, case reports, comments, editorials, and letters which did not report raw data. All studies with a diagnosis of HL not directly related to MVD surgery were excluded. All studies were published in English. Exclusion of non-English studies likely had no effect on the core findings and this criterion was adopted only for practical reasons with no intended bias toward international studies. Study participants were ! 18 years of age.
Target Conditions
TGN presents as intense pain on the ipsilateral side of the face. HFS presents as tonic and clonic contractions of the muscles innervated by the facial nerve. GPN patients suffer from severe nervous pain in the tongue, throat, ear, and tonsils. GN patients have severe pain in the deep ear, which may radiate outwards.
Data Extraction and Analysis
Two investigators (P. D. T. and G. C. C.) independently extracted relevant data from selected articles on the design and results of each study using a standardized form, which included first authors, year of publication, study population, region, BAEP use method, hearing evaluation, and methods quality. A final list of articles that met the study inclusion criteria for both the investigators was assembled. Our primary outcome for the study was HL 0 to 90 days postoperatively. We evaluated the BAEP changes during MVD to predict HL, the outcomes recorded from the studies.
We extracted data on the number of: True positives (TP), patients with postoperative HL and loss of response (LR) in intraoperative BAEPs; false negatives (FN), patients with HL, but normal BAEPs; true negatives (TN), patients without HL and normal BAEPs; false positives (FP), patients without HL but with abnormal BAEPs.
The data were used to construct 2 Â 2 tables. For each individual study, sensitivity and specificity BAEP changes to identify HL were calculated after categorizing patients into no change, and LR or SCs. In all studies, the threshold for LR was defined as a 100% Amplitude of Wave V (AwV) loss. Our previous study categorized BAEP changes with significant benefits to sensitivity and specificity.
12 Categorical discrimination was used because BAEP waveform latency and amplitude dynamically change during MVD, secondary to the degree of retraction and/or compression affecting the auditory nerve or its vasculature. Individual study's definition of the SC threshold was treated as valid. Studies using a threshold above the lowest value used by any study were not retroactively parsed.
Hearing Loss
Hearing loss was defined in several different ways among studies. Most studies used pre-and postoperative pure tone audiometry and/or speech discrimination scores (SDS) to determine HL. Bond et al (2010) used patient self-reporting to classify HL and Huang et al (2009) did not specify how they determined HL; in both cases, no HL was reported. Audiometric testing was not always stated as conducted by an audiologist, and in these cases, no reference to who conducted the testing was given. These two studies were excluded from the quantitative analysis. When a time frame was reported, testing occurred 2 to 90 days preoperatively and 0 to 90 days postoperatively. Among studies that reported a cutoff value for HL, the absolute value varied from 20 to 50 dB for pure tone audiometry (PTA) scores and 20 to 50% of SDS. If the answers to all signaling questions in a domain are "yes" then the "low" risk grade is given. If the answer to any signaling question is "no" then a "high" risk grade is given. The "unclear" category was only used where the reported data was insufficient to permit a judgment. The methodological quality of the included studies was assessed independently by two review authors and disagreement was resolved by reexamination of the primary literature.
Statistical Analysis
We used Stata 13 for the statistical analyses (Stata statistical software: release 13, StataCorp LP, College Station, Texas, United States). All p values were set at p ¼ 0.05. The primary analysis of this review was to fit the data into a hierarchical SROC (HSROC) model using the bivariate model, which has been demonstrated to yield useful summary measures of diagnostic test performance. 14 We were also able to obtain area under the receiver operating curve (AUROC), pooled sensitivity, and pooled sensitivity through the same bivariate model used in generating the HSROC. For pooled estimates of DOR, we used the Der-Simonian Laird random effects metaanalysis. A Fagan nomogram was constructed to assess the positive likelihood ratio (þLR), negative likelihood ratio (ÀLR), positive posterior probability, and negative posterior probability.
We did not include datasets in the pooled analysis if either TP þ FN ¼ 0 or TN þ FP ¼ 0, because it was not possible to accurately estimate sensitivity or specificity. In other instances, we corrected zero cell counts by adding a 0.5 continuity correction to the study data.
Heterogeneity
The amount of heterogeneity between the included studies was quantified with the I 2 statistic. In general, I 2 (> 50%)
shows that there is substantial variability or inconsistency in the results amongst the whole set of studies, whereas I 2 (< 50%) shows the included studies had consistent findings.
Results
Study Selection and Characteristics
The electronic search yielded a total of 121 publications (►Fig. 1). We rejected 94 publications as they did not meet the inclusion criteria. Of the two authors who screened the results, one author selected 25 studies for potential inclusion and one author selected 40 studies. After discrepancies were discussed, the full-text copies of 27 studies were included. Of these, 14 studies were excluded for reasons stated in the flow diagram (►Fig. 1) and 13 studies met the inclusion criteria for our review since they used an appropriate index and reference test in patients having MVD surgery.
Risk of Bias within Studies and Results of Individual Studies
Radtke and colleagues (1991) included 151 unmonitored patients, which made their selection of monitored patients, used in our meta-analysis, unclear. 8 Patient selection had a high risk of bias in Sindou et al (1992) due to nonrandom or consecutive sampling of patients. 15 One study had a high patient applicability concern because some patients in the analysis did not undergo MVD. 16 Seven out of 13 studies had a high-risk index test because they did not specify a threshold or a cutoff value for significant BAEP changes before surgery. 3, 5, 8, [17] [18] [19] [20] One study had a high applicability concern because not all patients received intraoperative monitoring. 8 The hearing evaluation risk of bias was unclear in three studies because no cutoff value in PTA scores or SDS was used to classify HL. 5, 18, 21 The hearing evaluation risk of bias was high in two studies because they evaluated HL clinically, or did not specify their method. 15, 16 The hearing evaluation applicability was unclear in two studies because HL criteria was not reported as PTA or SDS. 18, 21 The hearing evaluation applicability was of high concern in one study because patients subjectively requested auditory tests. 8 Flow and timing had an unclear risk in two studies 5, 18 and a high risk of bias in four studies. [15] [16] [17] 21 The high risk was due to three studies that did not include all patients in their analysis and one that did not give a hearing evaluation to all patients.
Only Thirumala et al (2014) adopted the diagnostic accuracy paradigm in their analysis and the other studies used individual cases to show BAEP change's correlation to postoperative HL. Methodological quality is presented in ►Table 1. Characteristics of included studies are presented in ►Tables 2 and 3.
Synthesis of Results and Risk of Bias
The total incidence of HL in our study is 4.88%. . The positive posterior probability was 15% (13, 17%) and the negative posterior probability was 2% (1, 2%).
Discussion
LR is used in practice to recognize patients at a high risk for HL. Patients who experience HL are 69 times more likely to have sustained an intraoperative loss of the BAEP response according to the DOR. The pooled specificity across studies was high (98%) but the sensitivity was low (74%) of BAEPs in evaluating HL after MVD. We classified patients who had 
27,28
SCs in the latency and amplitude of BAEPs during MVD are used in practice as an alarm so that the surgeon can be aware of the changing auditory nerve function. Patients who experience HL are nine times more likely to have sustained an intraoperative change (SC and LR) in BAEP response during MVD. The pooled sensitivity was higher as compared with LR, 88 versus 74 respectively. To prevent HL, we need a good alarm criterion which is sensitive and can be communicated to the surgical team during MVD. The current ACNS guidelines recommend as an alarm ! 1.0 ms or ! 10% increase in latency of wave V and/or a decrease in the amplitude ! 50%. 9, 10 In this review, three studies alerted the surgeon at a > 0.5 ms latency delay, three used some standard deviation in latency from baseline, and the majority adopted the recommended guidelines. The varied alarm criteria adopted in clinical practice may have to be robustly evaluated to improve sensitivity. Our study found that both SC þ LR and LR have þLR greater than one and ÀLR less than one. The þLR was higher for LR, indicating its value in predicting postoperative deficits. The -LR was higher for SC þ LR, indicating its value for preventing postoperative deficits. The postoperative probability was increased from 5% in LR and SC þ LR to 31 and 15%, respectively. The overall incidence of HL in our study was 2.20%. Technical issues such as anesthetic technique, temperature of the eighth cranial nerve, lead displacement, or dislodging of the sound generator in the ear canal may cause changes in BSERs which do not reflect hearing changes and add variability to all studies. The study by Jo et al provides 1,156/2,540 patients in the study sample which includes the results of other studies in the ROC analysis. Qualitative review and individual details of published studies is included to assuage this occlusion.
Although the current study showed strengths based on a comprehensive literature review, with quality assessment using the QUADAS-2, there are several limitations that must be addressed. Most importantly, owing to study design, our analysis is at risk of publication bias because of dependence on currently published data on the topic of investigation. Another major limitation is substantial heterogeneity in the findings of the individual studies, as evidenced by the wide variations in the sensitivities and specificities obtained. Because of high heterogeneity, a funnel plot could not be constructed. Moreover, "zero" event cells were not uncommon within this set of studies, and this precluded from reliably analyzing a few of the published studies.
Conclusions
Intraoperative of BAEPs changes are highly specific in predicting HL after MVD. Lower sensitivity is due to the therapeutic surgical pause in the MVD in response to changes in BAEPs. A loss of BAEPs during the procedure can be a specific, biomarker of perioperative HL. Patients undergoing MVD should have BAEP monitoring to prevent HL.
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